Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally. It operates through two segments: Pharmaceuticals and Consumer Products. It offers finished dosage human formulations, such as generics; branded generics; specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; animal healthcare products; and products in the therapeutic areas of pain management, neurology, metabolic disorder, and liver diseases. The company provides the products under the Everyuth, Nutralite, SugarFree, Complan, Glucon-D, and Nycil brands. In addition, the company offers a pipeline of biological products in the areas of oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology, and infectious illnesses. Further, it engages in the investment, animal health and veterinary, pharmacy retail, and manpower supply and administration activities. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is headquartered in Ahmedabad, India. Zydus Lifesciences Limited is a subsidiary of Zydus Family Trust.
तुलना करने के लिए मीट्रिक्स | ZYDU | पीअर्स समकक्ष - बारीकी से मेल खाने वाली कंपनियों से संबंधित मेट्रिक्स का औसत ZYDU: MOREPENLAB, LUPIN, JBCHEPHARM, SANOFI, INDSWFTLAB | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधZYDUपीअर्सक्षेत्र |
---|---|---|---|---|
पी/ई अनुपात | 25.6x | 36.7x | −0.6x | |
PEG अनुपात | 0.39 | 0.45 | 0.00 | |
क़ीमत/बुक | 5.4x | 6.9x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 5.2x | 5.3x | 3.2x | |
अपसाइड (विश्लेषक लक्ष्य) | 8.5% | −0.2% | 46.9% | |
उचित मूल्य अपसाइड | अनलॉक करें | −16.7% | 7.9% | अनलॉक करें |